Delivery Order SPE2DB22D3301-SPE2DB25FY6PM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Bridion 200 mg/2 ml vials with a ceiling value of $13,804.03. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. Performance of the order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials totaling $2,544.38 with a completion date of August 26, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $60,425.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order valued at $13,449.57 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $22,659.00 delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $12,673.71 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 ml vials on August 21, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $9,392.29 to AmerisourceBergen Drug Corp for Bridion 500 mg/5 mL vials (5 mL quantity) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $27,945.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,543.95 on September 3, 2025, for the supply of Bridion 200 mg/2 ml vials. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for ultimate completion on September 4, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,818.60 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Bridion 200 mg/2 mL vials. The contract, which is not set-aside and carries a firm fixed price, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of May 7, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY6PMDelivery Order
The Defense Logistics Agency awarded a $39,774.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management and serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Bridion, a neuromuscular blocking agent reversal medication, reflects AmerisourceBergen's ongoing role in supplying specialized pharmaceutical products to support Defense Health Agency and broader military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.8k | 6/20/25 |